Counselors in Carthage, MS Accepting Medicare
2 Counselors found. Showing 1 - 2
 Dana Moore, LPC NCC BC-TMH Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 128 W Franklin St, Carthage, MS 39051 Phone: 601-476-4700 |
Nittiya Kiera Triplett Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1306 Highway 35 N, Carthage, MS 39051 Phone: 769-274-2431 Fax: 601-298-0951 |
News Archive
New prostate cancer screening method combines existing tests to increase accuracy
Northwestern Medicine- is the first health care provider in the country to offer a new non-invasive blood test for prostate cancer that is nearly three times more accurate than the current standard prostate-specific antigen (PSA) blood test. Known as the Prostate Health Index (phi), the new test's accuracy will effectively remove the need for many men who test positive for elevated PSA levels to undergo a biopsy to achieve a reliable diagnosis.
FORTE study offers new and revealing window into outcomes of trauma patients
Trauma is a leading cause of disability in the world, resulting in more disability-adjusted life years than any other disease. While in-hospital, trauma-related mortality has decreased to just 4 percent in the U.S., little is known about what happens to the 96 percent of patients who survive their trauma injuries but may suffer debilitating long-term effects.
Latino population less likely to receive basic preventive tests, says study
"Prevention" is the new buzzword for health professionals and the new emphasis for containing future health care costs. Yet Latinos, who currently represent about 15 percent of the U.S. population, have the lowest level of preventive care of all racial and ethnic groups in the nation.
News outlets report on polio outbreaks in Central, East Africa
"Bad immunisation strategy has been blamed for an outbreak of polio, which has killed nearly 200 and is believed to have caused paralysis in more than 2,000 others across Angola, Congo and the Democratic Republic of the Congo," the Mail & Guardian writes in a story examining the emergence of the disease in the three countries and efforts to control it.
GTx reports top line results from toremifene Phase III clinical trial for prostate cancer
GTx, Inc. today announced top line results of the Phase III clinical trial evaluating toremifene 20 mg, a selective estrogen receptor modulator, for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia, or PIN, a premalignant lesion of the prostate.
› Verified 7 days ago